Filing Details

Accession Number:
0001209191-12-033545
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-12 18:56:14
Reporting Period:
2012-06-11
Filing Date:
2012-06-12
Accepted Time:
2012-06-12 17:56:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103390 Ardea Biosciences Inc. RDEA Pharmaceutical Preparations (2834) 943200380
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1292404 W John Beck 4939 Directors Place
San Diego CA 92121
Svp, Finance & Operations, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-11 28,048 $14.26 32,457 No 4 M Direct
Common Stock Disposition 2012-06-11 28,048 $31.97 4,409 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-06-11 28,048 $0.00 28,048 $14.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
155,952 2018-05-26 No 4 M Direct
Footnotes
  1. 25% of the shares subject to the stock option vest and become exercisable on May 27, 2009. The remaining shares vest in equal monthly installments over the following 3 years.